Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Hybridoma|December 1, 1995
Monoclonal antibodies directed against unique and common determinants on the lipopolysaccharide molecule of Salmonella serogroups A, B, and DT I Merkulova, S G Abbasova, A B MoshnikovaBioorganicheskaia Khimiia|September 9, 2011
[Preparation and characterization of monoclonal antibodies to Bacillus anthracis protective antigen]N V Rudenko, S G Abbasova, E V GrishinIzvestiia Akademii Nauk. Seriia Biologicheskaia|June 4, 1998
[Cell sensitivity to Fas-mediated apoptosis depends on three forms of Fas-antigen]I V Beletskaia, L F Nazarova, L V Nikonova, et al.Biochemistry. Biokhimiia|April 16, 2002
Changes in the balance between membrane-bound and soluble forms of CD95 (Fas) during selection of tumor cells in vivoA V Pirogov, S G Abbasova, N A Dyakova, et al.Bulletin of Experimental Biology and Medicine|September 8, 2000
Leptin and apoptosis inhibitor soluble Fas antigen in the serum of patients with osteosarcoma and neuroectodermal bone tumorsN E Kushlinskii, Y N Solov'ev, I V Babkina, et al.Bulletin of Experimental Biology and Medicine|July 23, 2008
Epitope mapping of human Fas using peptide phage displayS G Abbasova, Zh M Shcheprova, A G Laman, et al.Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|May 8, 2001
[Expression of the apoptosis inhibitor soluble Fas antigen in patients with malignant and benign bone neoplasms]N E Kushlinskiĭ, Iu N Solov'ev, I V Babkina, et al.Bulletin of Experimental Biology and Medicine|September 11, 2001
Soluble Fas antigen in the serum of patients with colon cancerN E Kushlinskii, T A Britvin, S G Abbasova, et al.Bulletin of Experimental Biology and Medicine|January 10, 2002
Soluble Fas antigen (sFAS) in the serum from patients with adrenal tumorsN E Kushlinskii, T A Britvin, G A Polyakova, et al.Bioorganicheskaia Khimiia|September 9, 2011
[Monoclonal antibodies to type A, B, E and F botulinum neurotoxins]S G Abbasova, N V Ruddenko, A Iu Gorokhovatskiĭ, et al.Pageof 2